92 related articles for article (PubMed ID: 14518256)
1. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
Musholt PB; Musholt TJ; Moley JF; Scheumann GF
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
[TBL] [Abstract][Full Text] [Related]
2. RET activation in medullary carcinomas.
Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
[No Abstract] [Full Text] [Related]
3. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S
Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269
[TBL] [Abstract][Full Text] [Related]
4. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
[TBL] [Abstract][Full Text] [Related]
5. [Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].
Frilling A; Bockhorn M; Kalinin V; Liedke M; Kaun M; Broelsch CE
Chirurg; 1997 Aug; 68(8):789-93. PubMed ID: 9377989
[TBL] [Abstract][Full Text] [Related]
6. Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.
Vandenbosch K; Renard M; Uyttebroeck A; Sciot R; Matthijs G; Legius E
Genet Couns; 2005; 16(1):95-100. PubMed ID: 15844786
[TBL] [Abstract][Full Text] [Related]
7. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
8. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
[TBL] [Abstract][Full Text] [Related]
9. Three novel mutations in the RET proto-oncogene.
Kalinin VN; Amosenko FA; Shabanov MA; Lubchenko LN; Hosch SB; Garkavtseva RF; Izbicki JR
J Mol Med (Berl); 2001 Oct; 79(10):609-12. PubMed ID: 11692159
[TBL] [Abstract][Full Text] [Related]
10. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
[TBL] [Abstract][Full Text] [Related]
11. The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma?
De Miguel M; Fernández-Santos JM; Trigo-Sánchez I; Matera I; Ceccherini I; Martín I; Romeo G; Galera-Davidson H
Lab Anim; 2003 Jul; 37(3):215-21. PubMed ID: 12869284
[TBL] [Abstract][Full Text] [Related]
12. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
[No Abstract] [Full Text] [Related]
13. Does phaster mean better?
Angrist M
Clin Chem; 1997 Mar; 43(3):424-6. PubMed ID: 9068584
[No Abstract] [Full Text] [Related]
14. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
[No Abstract] [Full Text] [Related]
15. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
[No Abstract] [Full Text] [Related]
16. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
[TBL] [Abstract][Full Text] [Related]
17. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
18. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
[No Abstract] [Full Text] [Related]
19. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
20. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
